Hanson McClain Advisors »

Aclaris Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $183 49 3.76
2023-09-30 $260 38 6.87

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding Aclaris Therapeutics

BML Capital Management
Deep Track Capital
BlackRock
RA Capital Management
Vivo Capital
Vanguard Capital Management
Frazier Life Sciences Management
Rock Springs Capital Management
Decheng Capital
Adage Capital Partners GP
Balyasny Asset Management
Citadel Advisors
Morgan Stanley
Geode Capital Management
State Street Corporation

View all funds holding Aclaris Therapeutics